Prevalence and risk factors for pulmonary artery systolic hypertension among sickle cell disease patients in Nigeria-Reference-Cited by-同舟云学术

Prevalence and risk factors for pulmonary artery systolic hypertension among sickle cell disease patients in Nigeria

Published:2008-06 Issue:6 Volume:83 Page:485-490
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Aliyu Zakari Y.,Gordeuk Victor,Sachdev Vandana,Babadoko Aliyu,Mamman Aisha I.,Akpanpe Peter,Attah Ester,Suleiman Yusuf,Aliyu Nurudeen,Yusuf Jamilu,Mendelsohn Laurel,Kato Gregory J.,Gladwin Mark T.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.21162/fullpdf

Reference24 articles.

1. http://www.who.int/genomics/public/Maphaemoglobin.pdf.

2. Sickle cell disease and pulmonary hypertension in Africa: A global perspective and review of epidemiology, pathophysiology, and management

3. Mortality In Sickle Cell Disease -- Life Expectancy and Risk Factors for Early Death

4. Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The antisickling agent, 5‐hydroxymethyl‐2‐furfural: Other potential pharmacological applications;Medicinal Research Reviews;2024-06-06

2. Prevalence of Pulmonary Hypertension among Sudanese Patients with Sickle Cell Disease;The Open Respiratory Medicine Journal;2024-05-21

3. Design, Synthesis, and Antisickling Investigation of a Thiazolidine Prodrug of TD-7 That Prolongs the Duration of Action of Antisickling Aromatic Aldehyde;Pharmaceutics;2023-10-28

4. Targeted modification of furan‐2‐carboxaldehydes into Michael acceptor analogs yielded long‐acting hemoglobin modulators with dual antisickling activities;Chemical Biology & Drug Design;2023-10-05

5. Pulmonary Hypertension and Left Ventricular Geometric Types in Sickle Cell Anemia;The American Journal of Cardiology;2023-09